Jack Lin
Stock Analyst at Morgan Stanley
(0.61)
# 4,296
Out of 5,118 analysts
29
Total ratings
38.1%
Success rate
-9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jack Lin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 2256 Abbisko Cayman Limited | Reiterated: Buy | $22.00 | $6.36 | +246.18% | 2 | Sep 4, 2026 | |
| HKG: 9926 Akeso, Inc. | Reiterated: Buy | $215.00 → $212.00 | $85.25 | +148.68% | 4 | Aug 26, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Reiterated: Buy | $123.00 → $138.50 | $86.35 | +60.39% | 2 | Aug 25, 2026 | |
| HKG: 9969 InnoCare Pharma Limited | Reiterated: Buy | $17.00 | $12.10 | +40.50% | 4 | Aug 25, 2026 | |
| HCM HUTCHMED (China) | Upgraded: Hold | $14 → $14 | $15.16 | -10.29% | 3 | May 28, 2026 | |
| HKG: 0013 HUTCHMED (China) Limited | Reiterated: Hold | $21.45 → $21.30 | $23.16 | -8.03% | 3 | May 28, 2026 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Reiterated: Buy | $493.00 | $104.90 | +369.97% | 2 | Nov 20, 2025 | |
| HKG: 9688 Zai Lab Limited | Reiterated: Buy | $37.50 → $37.44 | $18.36 | n/a | 2 | Nov 6, 2025 | |
| HKG: 9995 RemeGen Co., Ltd. | Reiterated: Hold | $89.00 | $70.20 | n/a | 2 | Oct 30, 2025 | |
| HKG: 1952 Everest Medicines Limited | Reiterated: Hold | $55.00 | $27.02 | n/a | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93.50 | $69.30 | n/a | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $25.48 | n/a | 3 | Sep 21, 2025 |
Abbisko Cayman Limited
Sep 4, 2026
Reiterated: Buy
Price Target: $22.00
Current: $6.36
Upside: +246.18%
Akeso, Inc.
Aug 26, 2026
Reiterated: Buy
Price Target: $215.00 → $212.00
Current: $85.25
Upside: +148.68%
Innovent Biologics, Inc.
Aug 25, 2026
Reiterated: Buy
Price Target: $123.00 → $138.50
Current: $86.35
Upside: +60.39%
InnoCare Pharma Limited
Aug 25, 2026
Reiterated: Buy
Price Target: $17.00
Current: $12.10
Upside: +40.50%
HUTCHMED (China)
May 28, 2026
Upgraded: Hold
Price Target: $14 → $14
Current: $15.16
Upside: -10.29%
HUTCHMED (China) Limited
May 28, 2026
Reiterated: Hold
Price Target: $21.45 → $21.30
Current: $23.16
Upside: -8.03%
Duality Biotherapeutics, Inc.
Nov 20, 2025
Reiterated: Buy
Price Target: $493.00
Current: $104.90
Upside: +369.97%
Zai Lab Limited
Nov 6, 2025
Reiterated: Buy
Price Target: $37.50 → $37.44
Current: $18.36
Upside: n/a
RemeGen Co., Ltd.
Oct 30, 2025
Reiterated: Hold
Price Target: $89.00
Current: $70.20
Upside: n/a
Everest Medicines Limited
Sep 22, 2025
Reiterated: Hold
Price Target: $55.00
Current: $27.02
Upside: n/a
Sep 22, 2025
Reiterated: Buy
Price Target: $93.50
Current: $69.30
Upside: n/a
Sep 21, 2025
Reiterated: Buy
Price Target: $50 → $48
Current: $25.48
Upside: n/a